Search Results - "Lebel, Francois"

Refine Results
  1. 1

    Void content analysis and processing issues to minimize defects in liquid composite molding by LeBel, François, Ruiz, Édu, Trochu, François

    Published in Polymer composites (01-01-2019)
    “…This investigation aims to study the impact of key process parameters dealing with the resin impregnation of fibrous reinforcements used in Liquid Composite…”
    Get full text
    Journal Article
  2. 2

    Influence of habitat features and hunter behavior on white-tailed deer harvest by Lebel, François, Dussault, Christian, Massé, Ariane, Côté, Steeve D.

    Published in The Journal of wildlife management (01-09-2012)
    “…Sport hunting may help in controlling cervid populations over large areas. As with natural predators, several environmental factors can influence sport…”
    Get full text
    Journal Article
  3. 3

    Prediction of optimal flow front velocity to minimize void formation in dual scale fibrous reinforcements by LeBel, François, Fanaei, Amir Ershad, Ruiz, Édu, Trochu, François

    Published in International journal of material forming (01-03-2014)
    “…Liquid Composite Molding (LCM) is an increasingly used class of processes to manufacture high performance composites. Engineering fabrics commonly used in LCM…”
    Get full text
    Journal Article
  4. 4

    Experimental characterization by fluorescence of capillary flows in dual-scale engineering fabrics by LeBel, François, Fanaei, Amir Ershad, Ruiz, Eduardo, Trochu, François

    Published in Textile research journal (01-09-2013)
    “…Liquid composite molding (LCM) is an increasingly used family of processes to manufacture composite parts. In LCM, the fibrous reinforcement is first laid in a…”
    Get full text
    Journal Article
  5. 5

    Flow modeling of linear and nonlinear fluids in two and three scale fibrous fabrics by Lopez, Elena, Abisset-Chavanne, Emmanuelle, Lebel, François, Upadhyay, Ram, Comas, Sébastien, Binetruy, Christophe, Chinesta, Francisco

    Published in International journal of material forming (01-04-2016)
    “…A crucial step in many composites manufacturing processes is the impregnation of fibrous medium with the resin. The fundamental property needed to quantify the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Advanced thermal simulation of processes involving materials exhibiting fine-scale microstructures by Lopez, Elena, Abisset-Chavanne, Emmanuelle, Lebel, François, Upadhyay, Ram, Comas, Sébastien, Binetruy, Christophe, Chinesta, Francisco

    Published in International journal of material forming (01-04-2016)
    “…Image-based simulation is being considered more and more in industrial applications, where more than simulate the expected reality it seems preferable to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients by Le, Xiuning, Goldman, Jonathan Wade, Clarke, Jeffrey Melson, Tchekmedyian, Nishan, Piotrowska, Zofia, Chu, David, Bhat, Gajanan, Lebel, Francois M., Socinski, Mark A.

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 9514 Background: Treatment of non-small cell lung cancer (NSCLC) with EGFR exon 20 mutations is an unmet medical need. Poziotinib is a potent…”
    Get full text
    Journal Article
  10. 10

    Cost-effectiveness of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in children with mild to moderate dehydration by Mace, Sharon E., MD, Harb, George, MD, Friend, Keith, MD, Turpin, Robin, PhD, Armstrong, Edward P., PharmD, Lebel, Francois, MD

    Published in The American journal of emergency medicine (01-06-2013)
    “…Abstract Objective To evaluate the cost-effectiveness of recombinant human hyaluronidase–facilitated subcutaneous (rHFSC) fluid administration compared to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial by Le, Xiuning, Cornelissen, Robin, Garassino, Marina, Clarke, Jeffrey M, Tchekmedyian, Nishan, Goldman, Jonathan W, Leu, Szu-Yun, Bhat, Gajanan, Lebel, Francois, Heymach, John V, Socinski, Mark A

    Published in Journal of clinical oncology (01-03-2022)
    “…Insertion mutations in Erb-b2 receptor tyrosine kinase 2 gene ( or ) exon 20 occur in 2%-5% of non-small-cell lung cancers (NSCLCs) and function as an…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE) by Jalal, Shadia I, Lavin, Philip, Lo, Gregory, Lebel, Francois, Einhorn, Lawrence

    Published in Journal of clinical oncology (10-08-2017)
    “…Purpose To evaluate the efficacy of the addition of palifosfamide to carboplatin and etoposide in extensive stage (ES) small-cell lung cancer (SCLC). Patients…”
    Get full text
    Journal Article
  16. 16

    Abstract PD1-07: A Phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer heavily pre-treated with HER2-targeted therapy by Brufsky, Adam, Zulfiqar, Malik, Peguero, Julio, Lathrop, Kate, Bhat, Gajanan, Lebel, Francois

    Published in Cancer research (Chicago, Ill.) (15-02-2021)
    “…Abstract Background: Poziotinib is a novel pan-HER inhibitor that irreversibly blocks the EGFR family of tyrosine-kinase receptors and inhibits the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Justification for a Fixed Dose of Eflapegrastim, a Long‐Acting G‐CSF, in Patients Receiving Docetaxel‐Cyclophosphamide Chemotherapy by Barrett, John A., Greene, Douglas, Lakshmikanthan, Sribalaji, Kolli, Prasad, Chawla, Shanta, Lebel, Francois

    Published in Journal of clinical pharmacology (01-02-2021)
    “…Eflapegrastim (Rolontis) is a long‐acting granulocyte colony‐stimulating factor (G‐CSF) produced by conjugating a human G‐CSF analogue and a human…”
    Get full text
    Journal Article
  20. 20